Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Item No. 36723

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BAM-22P is an endogenous neuropeptide derived from proenkephalin A.1 It is expressed primarily in the adrenal medulla and at lower concentrations throughout the brain. BAM-22P binds µ-, κ-, and δ-opioid receptors (Kis = 0.9, 2.9, and 7.2 nM, respectively).2 Intracerebroventricular administration of BAM-22P induces analgesia in a tail-flick assay in mice (ED50 = 6.4 nM).1 It decreases the frequency of tail flicking, as well as paw lifting and licking in a rat model of formalin-induced nocifensive behavior when administered intrathecally at a dose of 5 nM/animal.3
WARNING This product is not for human or veterinary use.
1. Pro-
2. Endogenous opioid peptides: Comparative evaluation of their receptor affinities in the mouse brain. Life Sci. 33(Suppl 1), 291-294 (1983).
3. Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain—potential function of a novel receptor. Br. J. Pharmacol. 141(3), 423-430 (2004).